{
  "id": "fda-clears-first-human-trial-of-epigenetic-reprogramming-therapy",
  "title": "FDA clears first human trial of epigenetic reprogramming therapy",
  "summary": "A milestone moment for longevity as Life Biosciences gets green light to progress cellular rejuvenation trial in eye disease. Two decades ago, Professor Shinya Yamanaka discovered a groundbreaking method to reverse the biological age of cells. The Nobel prize-winning discovery sparked a global race to harness the approach therapeutically, and today marks a historic milestone [â€¦] The post FDA clears first human trial of epigenetic reprogramming therapy appeared first on Longevity.Technology.",
  "url": "https://longevity.technology/news/fda-clears-first-human-trial-of-epigenetic-reprogramming-therapy/",
  "source": "Longevity.Technology",
  "author": "Danny Sullivan",
  "category": "news",
  "publishedAt": "2026-01-28T14:17:03.000Z",
  "fetchedAt": "2026-02-04T10:49:05.821Z",
  "relevanceScore": 0.9,
  "matchedKeywords": [
    "longevity",
    "epigenetic",
    "yamanaka",
    "biological age"
  ],
  "relatedProducts": [],
  "type": "web",
  "savedAt": "2026-02-04T10:49:05.845Z"
}